AstraZeneca Pharma India Limited — Others, 12-12-2024: Trading Window

AstraZeneca Pharma India Limited has announced a board meeting on the closure of the trading window for its equity shares, effective from December 16, 2024. The window will reopen 48 hours after the declaration of the financial results for the quarter ending December 31, 2024.

This move underscores the company’s commitment to compliance with insider trading regulations, ensuring that all market participants operate on a level playing field. Investors should remain vigilant, as this period of restricted trading may create volatility and could influence sentiment depending on the upcoming financial results.